Vivera Pharmaceuticals and diagnostic testing distributor Areum Bio have announced their channel partnership to expand the distribution of Access Bio’s CareStart Covid-19 rapid antigen test and other products granted Emergency Use Authorization (EUA) by the US Food and Drug Administration (FDA). Areum already distributes the CareStart test, and will seek to strengthen its supply chain efforts for rapid tests expansion and accessibility with Vivera’s extensive network.
XPhyto Therapeutics has entered into a master supply agreement with Beovita GmbH & Co. KG and Tackleberries GmbH, two German diagnostics, testing, and medical logistics companies that operate ten Covid-19 test centres in Berlin, Germany. The test will be offered to consumers as a rapid PCR test with sample collection and processing on site. Commercial operations are scheduled to begin once the test kits are delivered.
Go deeper with GlobalData
SpeeDx, a molecular diagnostic solutions company, and MolGen, an industrial automation firm, have agreed to collaborate on the supply and distribution of clinical diagnostics products and instrumentation across the Asia Pacific and Europe. The partnership aims to combine MolGen liquid handling and purpose-built automation with SpeeDx Covid-19 diagnostic solutions to extend a full workflow offering to pathology laboratories.
